Abstract
Objectives
To study the Hepatitis A virus (HAV) infection-related pediatric liver disease burden.
Methods
Hospital records of 431 children (age <18 y) diagnosed to be suffering from acute HAV infection during 2011 to 2018 were extracted and analyzed. Additionally, a seroprevalence study was done on 2599 participants (696 children and 1903 adults).
Results
HAV infection accounted for about half (48.6% of acute hepatitis and 46.5% (92/198) of acute liver failure cases) of all acute onset icteric illness, with significant morbidity and mortality. As per seroprevalence data, 16.2% of children between 10–18 years of age, and 10.3% of adults aged 18–30 years remained susceptible to HAV infection.
Conclusion
HAV infection is the major contributor the overall pediatric liver disease burden. A significant proportion of subjects remain susceptible to HAV infection even after 10 years of age. Population-based studies are required to further delineate the epidemiology of HAV infection in India for deciding introduction of HAV vaccine in the national immunization schedule.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Yachha SK, Goel A, Khanna V, Poddar U, Srivastava A, Singh U. Ascitic form of sporadic acute viral hepatitis in children: A distinct entity for recognition. J Pediatr Gastroenterol Nutr. 2010;50:184–7.
Alam S, Khanna R, Sood V, Lal BB, Rawat D. Profile and outcome of first 109 cases of paediatric acute liver failure at a specialized paediatric liver unit in India. Liver Int. 2017;37:1508–14.
Alam S, Lal BB, Sood V, Rawat D. Pediatric acute-on-chronic liver failure in a specialized liver unit: Prevalence, profile, outcome and predictive factors. J Pediatr Gastroenterol Nutr. 2016;63:400–5.
Aggarwal R, Goel A. Hepatitis A: epidemiology in resource-poor countries. Curr Opin Infect Dis. 2015;28:488–96.
Squires RH Jr, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz MR et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148:652–658.
Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, et al; APASL ACLF Research Consortium (AARC) for APASL ACLF working Party. Acute-on-chronic Liver Failure: Consensus Recommendations of the Asian Pacific Association for the Study of the Liver (APASL): An Update. Hepatol Int. 2019 Jun 6. [Epub ahead of print]
Morbidity and Mortality Weekly Report (MMWR): Viral Hepatitis Surveillance—India, 2011–2013. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6428a3.htm. Accessed September 7, 2018.
WHO vaccine-preventable diseases: monitoring system. 2018 global summary. Available from: http://apps.who.int/immunization_monitoring/globalsummary/countries?countrycriteria%5Bcountry%5D%5B%5D=IND&commit=OK. Accessed September 9, 2018.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–128.
Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L. Hepatitis A: Epidemiology and prevention in developing countries. World J Hepatol. 2012;4:68–73.
Gripenberga M, D’Corb NA, L’Azouc M, Marshd G, Druellesc S, Nealon J. Changing sero-epidemiology of hepatitis A in Asia-Pacific countries: A systematic review. Int J Infect Dis. 2018; 68:13–7.
Arankalle V, Mitra M, Bhave S, Ghosh A, Balasubramanian S, Chatterjee S, et al. Changing epidemiology of hepatitis A virus in Indian children. Vaccine: Development and Therapy. 2014;4:7–13.
Yao G. Clinical spectrum and natural history of viral hepatitis A in a 1988 Shanghai epidemic. In: Hollinger FB, Lemon SM, Margolis H, editors. Viral Hepatitis and Liver Disease: Proceedings of the 1990 International Symposium. Baltimore, MD: Williams and Wilkins; 1991. p. 76 80.
Arankalle VA, Sarada Devi KL, Lole KS, Shenoy KT, Verma V, Haneephabi M. Molecular characterization of hepatitis A virus from a large outbreak from Kerala, India. Indian J Med Res. 2006;123:760–9.
Rakesh P, Sherin D, Sankar H, Shaji M, Subhagan S, Salila S. Investigating a community-wide outbreak of hepatitis A in India. J Glob Infect Dis. 2014;6:59–64.
Vizzotti C, González J, Gentile A, Rearte A, Ramonet M, Cañero-Velasco MC, et al. Impact of the single-dose immunization strategy against hepatitis A in Argentina. Pediatr Infect Dis J. 2014;33:84–8.
Vizzotti C, Pippo T, Uruena A, Altuna J, Palópoli G, Hernández ML, et al. Economic analysis of the singledose immunization strategy against hepatitis A in Argentina. Vaccine. 2015;33:A227–32.
Dagan R, Leventhal A, Anis E, Slater P, Ashur Y, Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA. 2005;294:202–10.
Chironna M, Prato R, Sallustio A, Martinelli D, Tafuri S, Quarto M, et al. Hepatitis A in Puglia (South Italy) after 10 years of universal vaccination: need for strict monitoring and catch-up vaccination. BMC Infect Dis. 2012; 12:271.
Cui F, Hadler SC, Zheng H, Wang F, Zhenhua W, Yuansheng H, et al. Hepatitis A surveillance and vaccine use in China from 1990 through 2007. J Epidemiol. 2009;19:189–95.
Suwantika AA, Yegenoglu S, Riewpaiboon A, Tu HA, Postma MJ. Economic evaluations of hepatitis A vaccination in middle income countries. Expert Rev Vacc. 2013;12:1479–94.
No authors listed. WHO position paper on hepatitis A vaccines - June 2012. Wkly Epidemiol Rec. 2012;87:261-76.
Funding
Funding: None.
Author information
Authors and Affiliations
Contributions
Contributors: VS, BBL, RK and MKS contributed to data collection and writing the initial draft of manuscript; EG, RK and SA conceptualized the study, and supervised the editing and revision of manuscript. All authors approved the final version of manuscript, and are accountable for all aspects related to the study.
Corresponding author
Additional information
Competing Interest: None stated.
Rights and permissions
About this article
Cite this article
Sood, V., Lal, B.B., Gupta, E. et al. Hepatitis A Virus-related Pediatric Liver Disease Burden and its Significance in the Indian Subcontinent. Indian Pediatr 56, 741–744 (2019). https://doi.org/10.1007/s13312-019-1640-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-019-1640-1